Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Triple Negative Breast Neoplasms × Injections × 30 days × Clear all

Sponsor

Conditions

Leukemia, Myeloid, Acute 17 Myelodysplastic Syndromes 6 Leukemia, Myelomonocytic, Chronic 5 Myeloproliferative Disorders 3 Prostatic Neoplasms 2 Precursor Cell Lymphoblastic Leukemia-Lymphoma 2 Ovarian Neoplasms 2 Leukemia, Monocytic, Acute 2 Advanced Solid Tumour 2 Uterine Cervical Neoplasms 1 Thrombocythemia, Essential 1 Strabismus 1 Solid Tumor 1 Sarcoma 1 Primary Myelofibrosis 1 Polycythemia Vera 1 Non-Squamous Non-small Cell Lung Cancer 1 Non-Muscle Invasive Bladder Neoplasms 1 Neoplasms 1 Myelodysplastic-Myeloproliferative Diseases 1 Multiple Sclerosis 1 Melanoma 1 Lymphoma, T-Cell 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma 1 Lung Neoplasms 1 Leukemia, Myelomonocytic, Acute 1 Leukemia, Biphenotypic, Acute 1 Leukemia, Basophilic, Acute 1 Idiopathic Pulmonary Fibrosis 1

Interventions

pembrolizumab 21 Specimen Handling 12 Paclitaxel 11 Magnetic Resonance Spectroscopy 11 Carboplatin 11 Biopsy 10 olaparib 7 Gemcitabine 5 Capecitabine 5 130-nm albumin-bound paclitaxel 5 eribulin 4 Taxes 4 Doxorubicin 4 X-Rays 3 Nivolumab 3 Cyclophosphamide 3 Cisplatin 3 tucatinib 2 sargramostim 2 liposomal doxorubicin 2 durvalumab 2 ceralasertib 2 Trastuzumab 2 Standard of Care 2 Platinum 2 Immunoglobulin G 2 Fulvestrant 2 Drug Therapy 2 Docetaxel 2 Colony-Stimulating Factors 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡